moxifloxacin has been researched along with Hidradenitis Suppurativa in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duarte, R; Macedo, R; Mendes-Bastos, P | 1 |
| Bettoli, V; Join-Lambert, O; Nassif, A | 1 |
| Behillil, S; Berche, P; Coignard, H; Consigny, PH; Fraitag, S; Guet-Revillet, H; Jais, JP; Join-Lambert, O; Jullien, V; Le Guern, AS; Leflèche, A; Lortholary, O; Nassif, A; Nassif, X; Poirée, S; Ribadeau-Dumas, F; Thèze, J | 1 |
| Carlson, EM; Meskin, SW | 1 |
2 review(s) available for moxifloxacin and Hidradenitis Suppurativa
| Article | Year |
|---|---|
Antibiotic Treatment of Hidradenitis Suppurativa.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Clindamycin; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Imipenem; Maintenance Chemotherapy; Metronidazole; Moxifloxacin; Remission Induction; Rifampin | 2016 |
Mooren's-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review.
Topics: Amnion; Antibodies, Monoclonal; Aza Compounds; Conjunctiva; Corneal Perforation; Corneal Ulcer; Dermatologic Agents; Disease Progression; Doxycycline; Drug Therapy, Combination; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Moxifloxacin; Prednisolone; Prednisone; Quinolines; Severity of Illness Index; Treatment Outcome; Visual Acuity | 2011 |
2 other study(ies) available for moxifloxacin and Hidradenitis Suppurativa
| Article | Year |
|---|---|
Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Clindamycin; Contraindications, Drug; Drug Administration Schedule; Drug Therapy, Combination; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2017 |
Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.
Topics: Adult; Anti-Infective Agents; Antibiotics, Antitubercular; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Metronidazole; Middle Aged; Moxifloxacin; Prognosis; Quinolines; Recurrence; Remission Induction; Retrospective Studies; Rifampin; Treatment Outcome; Young Adult | 2011 |